Applied DNA Sciences

Applied DNA Sciences, Inc. is a biotechnology company that specializes in the development and commercialization of DNA-based technology solutions. Founded in 1983 and headquartered in Stony Brook, New York, the company has established itself as a leader in the field of molecular technology. Applied DNA Sciences utilizes its proprietary LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform to produce high-fidelity synthetic DNA sequences for various applications. This innovative platform enables the cell-free manufacture of DNA, which is crucial for nucleic acid-based therapeutics and other biotechnological applications. The company operates through three primary segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment focuses on the development and commercialization of the LinearDNA platform, which is used to produce synthetic DNA for use in therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics and laboratory testing services, including COVID-19 testing. This segment also offers polymerase chain reaction (PCR) testing for the detection of DNA and RNA, as well as isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers a range of products designed to authenticate goods within complex supply chains. These products include SigNature Molecular Tags, which provide a method for authenticating materials such as cotton and nutraceuticals. The company also offers SigNify portable DNA readers and consumable reagent test kits, as well as fiberTyping, a PCR-based DNA detection method used for product provenance authentication and supply chain security. Applied DNA Sciences is committed to leveraging its molecular technology to enhance security, integrity, and quality across various industries. The company's solutions are designed to provide the highest levels of security, deterrence, and legal recourse strength. Through its wholly owned subsidiary, LineaRx, Inc., Applied DNA Sciences supplies DNA for use in in vitro medical diagnostics, preclinical biotechnology, and drug and biologic development and manufacturing markets. The company is also engaged in preclinical and animal drug candidate development, focusing on therapeutically relevant DNA constructs manufactured via its PCR-based DNA production platform. With a strong emphasis on innovation and quality, Applied DNA Sciences continues to expand its reach and impact in the biotechnology sector. The company's advanced DNA-based solutions are helping to create secure and flourishing environments that foster success and integrity in various industries. {"description":"Applied DNA Sciences, Inc. is a biotechnology company that specializes in the development and commercialization of DNA-based technology solutions. Founded in 1983 and headquartered in Stony Brook, New York, the company has established itself as a leader in the field of molecular technology. Applied DNA Sciences utilizes its proprietary LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform to produce high-fidelity synthetic DNA sequences for various applications. This innovative platform enables the cell-free manufacture of DNA, which is crucial for nucleic acid-based therapeutics and other biotechnological applications. The company operates through three primary segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment focuses on the development and commercialization of the LinearDNA platform, which is used to produce synthetic DNA for use in therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics and laboratory testing services, including COVID-19 testing. This segment also offers polymerase chain reaction (PCR) testing for the detection of DNA and RNA, as well as isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers a range of products designed to authenticate goods within complex supply chains. These products include SigNature Molecular Tags, which provide a method for authenticating materials such as cotton and nutraceuticals. The company also offers SigNify portable DNA readers and consumable reagent test kits, as well as fiberTyping, a PCR-based DNA detection method used for product provenance authentication and supply chain security. Applied DNA Sciences is committed to leveraging its molecular technology to enhance security, integrity, and quality across various industries. The company's solutions are designed to provide the highest levels of security, deterrence, and legal recourse strength. Through its wholly owned subsidiary, LineaRx, Inc., Applied DNA Sciences supplies DNA for use in in vitro medical diagnostics, preclinical biotechnology, and drug and biologic development and manufacturing markets. The company is also engaged in preclinical and animal drug candidate development, focusing on therapeutically relevant DNA constructs manufactured via its PCR-based DNA production platform. With a strong emphasis on innovation and quality, Applied DNA Sciences continues to expand its reach and impact in the biotechnology sector. The company's advanced DNA-based solutions are helping to create secure and flourishing environments that foster success and integrity in various industries.